Octopus Group

Pelago Announces $58 Million Series C Funding to Strengthen Leadership in Substance Use Management

Retrieved on: 
Thursday, March 28, 2024
Mental Health, Mobile, Wireless, Technology, Hospitals, Telemedicine, Virtual Medicine, Software, Internet, Managed Care, General Health, Health, Factitious disorder, ROI, Growth, Y Combinator, Partnership, Suds, Research, Atomico, Human, Live Nation Entertainment, Octopus Group, Tobacco, Kinnevik AB, Absenteeism, Life, WTW, Series, Multimedia, Pharmaceutical industry

Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new funding on the strength of customer growth and validated ROI, bringing total funding to $151 million.

Key Points: 
  • Pelago , the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new funding on the strength of customer growth and validated ROI, bringing total funding to $151 million.
  • View the full release here: https://www.businesswire.com/news/home/20240328996003/en/
    The additional capital raised will help Pelago accelerate its product roadmap, extend its continuum of care and advance clinical research efforts.
  • As part of this latest round, Atomico Partner Laura Connell will join the Pelago board.
  • “I’m so proud of the work we have done to improve lives and expand access to substance use care that works.

Biofidelity raises $24 million in new financing to accelerate commercialization and expand product pipeline

Retrieved on: 
Wednesday, April 3, 2024
Lung cancer, LBA, Conference, Growth, NSCLC, Partnership, Patient, NGS, Biomarker, Research, Octopus Group, Laboratory, Medicine, AACR, Agilent Technologies, Pharmaceutical industry

Additionally, the new investment will enable the establishment of a dedicated manufacturing facility in the United Kingdom and drive pipeline expansion efforts across the Company's innovative technology platforms.

Key Points: 
  • Additionally, the new investment will enable the establishment of a dedicated manufacturing facility in the United Kingdom and drive pipeline expansion efforts across the Company's innovative technology platforms.
  • "This significant investment underlines the confidence of our investors in Biofidelity's unique technologies and our mission to bring the benefits of precision medicine to all patients," said Biofidelity Co-Founder and CEO Dr. Barnaby Balmforth.
  • The new funding round includes fresh commitments from current investors including Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures.
  • "We are thrilled to continue our partnership with Biofidelity as the team embarks on the next phase of their growth and commercial expansion."

HR Solution Remofirst Raises $25 Million Series A Funding to Make it Affordable and Easy to Employ Global Remote Teams

Retrieved on: 
Wednesday, March 6, 2024
Software, Technology, Professional Services, Human Resources, QED, Octopus Group, Multimedia, Volodymyr, Mastercard, World Health Organization, Organization, Tax, Zocdoc, Organizational founder, Cryptocurrency

View the full release here: https://www.businesswire.com/news/home/20240306357812/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240306357812/en/
    Remofirst cofounders Nurasyl Serik (left) and Volodymyr Fedoriv, who saw a need for a simple and affordable way for companies to legally and compliantly employ global teams, today announced $25 million in Series A venture capital funding.
  • This additional funding is a huge milestone for Remofirst, validating its vision for the future of global distributed teams and our superior solution that is affordable and easy to use.
  • The Remofirst solution leverages local in-country legal experts to ensure that its contracts are compliant in all locations, avoiding misclassification risks.
  • Prior to its Series A round, Remofirst raised $14.1 million in Seed funding in 2022.

Gen-Z Favorite Photo-Sharing App Lapse Closes $30 Million in Series A Funding to Build a New Kind of Social Media

Retrieved on: 
Tuesday, February 27, 2024
Engineering, GV (company), Social media, Roblox, Octopus Group, Snap Inc., GV, General partnership, Friends, Science, Pinterest, Camera

The raise validates a year of exponential growth for Lapse, which became the most downloaded app in the Apple US & UK app stores.

Key Points: 
  • The raise validates a year of exponential growth for Lapse, which became the most downloaded app in the Apple US & UK app stores.
  • As Lapse has grown, Co-founders Ben and Dan have prioritized evolving the app to meet the needs of its community.
  • We've only scratched the surface of our grander vision: To build a new kind of social media," says Co-founder Dan Silvertown.
  • For more information about Lapse and its pioneering approach to capturing and sharing photos, please visit lapse.com .

Gen-Z Favorite Photo-Sharing App Lapse Closes $30 Million in Series A Funding to Build a New Kind of Social Media

Retrieved on: 
Tuesday, February 27, 2024
Engineering, GV (company), Social media, Roblox, Octopus Group, Snap Inc., GV, General partnership, Friends, Science, Pinterest, Camera

The raise validates a year of exponential growth for Lapse, which became the most downloaded app in the Apple US & UK app stores.

Key Points: 
  • The raise validates a year of exponential growth for Lapse, which became the most downloaded app in the Apple US & UK app stores.
  • As Lapse has grown, Co-founders Ben and Dan have prioritized evolving the app to meet the needs of its community.
  • We've only scratched the surface of our grander vision: To build a new kind of social media," says Co-founder Dan Silvertown.
  • For more information about Lapse and its pioneering approach to capturing and sharing photos, please visit lapse.com .

VCTA research shows international ambitions for British scale-ups

Retrieved on: 
Thursday, December 7, 2023
Software, Online Retail, Other Retail, Professional Services, Fintech, Electronic Commerce, Technology, Small Business, Retail, Other Professional Services, Finance, Other Technology, Research, VCT, Etsy, Growth, Octopus Group, Renewable energy, Papier

Research from the Venture Capital Trust Association (VCTA) reveals how successful VCT companies have been to identify the next generation of ambitious British businesses.

Key Points: 
  • Research from the Venture Capital Trust Association (VCTA) reveals how successful VCT companies have been to identify the next generation of ambitious British businesses.
  • This research shows that the UK’s start-ups and scale-ups are seeking to capitalise on international growth opportunities.
  • The data showed that the desire to scale UK companies into international markets was consistent throughout the growth of a business.
  • Will Fraser-Allen, Chair of the VCTA, said: “Our research shows that VCTs are helping to identify and grow the next generation of global British companies.

Automata Technologies: Joe Stringer appointed Executive Chairman & Director of Corporate Development (EMEA)

Retrieved on: 
Monday, November 6, 2023
Biotechnology, Technology, Manufacturing, Health, Pharmaceutical, Robotics, Research, Engineering, Science, Machinery, Electronic Design Automation, The Royal Marsden NHS Foundation Trust, Francis Crick Institute, Octopus Group, Investment, Drug development, Ernst, NHS, Growth, Google Health, Ernst & Young, Royal Marsden Hospital, Corporate development, Holland & Barrett, Patient, Automation, Management, Pharmaceutical industry, Automaton

Automata Technologies (‘Automata’ or the ‘Company’), a leading automation company powering life sciences labs, has appointed Joe Stringer Executive Chairman and Director of Corporate Development for the UK and EMEA.

Key Points: 
  • Automata Technologies (‘Automata’ or the ‘Company’), a leading automation company powering life sciences labs, has appointed Joe Stringer Executive Chairman and Director of Corporate Development for the UK and EMEA.
  • Joe joins Automata from Octopus Ventures where he was most recently Head of Healthtech Investments.
  • Through his role at Octopus Ventures, Joe has been involved with Automata since January 2022 as an investor and Investor Director, and remains on the Board of Directors.
  • Mostafa Elsayed, Founder and CEO of Automata, commented:
    "It is great to welcome Joe to the Automata family full-time.

Automata Technologies: $40m fundraise backed by Dimension and A.P. Moller Holding, to expand growing life science lab automation offering

Retrieved on: 
Tuesday, October 3, 2023
Biotechnology, Technology, Manufacturing, Health, Pharmaceutical, Robotics, Research, Engineering, Science, Machinery, Electronic Design Automation, AstraZeneca, Francis Crick Institute, Unilab, Data collection, Royal Marsden Hospital, Octopus Group, LINQ, Growth, Entrepreneurship, The Royal Marsden NHS Foundation Trust, NHS, HSL, Trust, ChromeOS, Automation, Fine chemical, Video game, Pharmaceutical industry, Cryptocurrency, Automaton

This is happening at the same time as they struggle to find laboratory real estate as well as finding and retaining skilled lab staff.

Key Points: 
  • This is happening at the same time as they struggle to find laboratory real estate as well as finding and retaining skilled lab staff.
  • This convergence is leading to organisations rethinking their tooling, data infrastructure and ability to experiment at scale.
  • Moller Holding, added:
    ““We are delighted to partner with Automata, an emerging leader in modernizing and automating the global life science industry.
  • Automata’s solutions help increase throughput, lower cost, and accelerate innovation allowing its customers to focus on pushing further into cutting edge medical and life science research.”

Ibex Raises $55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis

Retrieved on: 
Wednesday, September 6, 2023
University, Marie Cassidy, Pathology, Cancer, KLAS, AstraZeneca, Research report, TEL, University of Pittsburgh Medical Center, Hospital, Octopus Group, Laboratory, Daiichi Sankyo, Diagnosis, Entrepreneurship, UPMC, AI, Growth, Health, Breast cancer, Medical device, Ibex

TEL AVIV, Israel, Sept. 6, 2023 /PRNewswire/ -- Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, today announced it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100 million since Ibex's inception in 2016.

Key Points: 
  • The financing brings total funding to over $100 million since Ibex's inception in 2016.
  • Ibex is transforming cancer diagnostics with AI-powered solutions that help pathologists improve the quality of diagnosis and support laboratories with enhanced efficiency and better turnaround times.
  • Cancer incidence is rising around the world while its diagnosis becomes more complex and nuanced, causing heavy workloads for pathologists and laboratories.
  • We are eager to see Ibex forge the way with new uses of AI in cancer diagnosis, supporting providers as they work to improve patient care and outcomes."

China Gaotang: Extending the Industrial Chain and Accelerating the Cultivation of Clusters

Retrieved on: 
Thursday, August 10, 2023
Taste, Food, Octopus Group, Pajama Party (group), Printing, Tax, Dicarboxylic acid, Maillard, Protein, Paper, R, Sucrose, Fine chemical

Gaotang County, Shandong Province has solidly promoted new breakthroughs in major industrial projects and made every effort to push project construction work to a new level.

Key Points: 
  • Gaotang County, Shandong Province has solidly promoted new breakthroughs in major industrial projects and made every effort to push project construction work to a new level.
  • Adhere to high standard planning and continuously expand industrial clusters.
  • Since the beginning of this year, Gaotang  has implemented 57 key projects with a total investment of 24.834 billion yuan.
  • Focusing on leading industrial chains such as equipment manufacturing, health food, paper and printing, we will make up for the shortcomings of the industrial chain, stretch the industrial chain, accelerate the cultivation of "wild goose formation" clusters and characteristic industrial clusters, and strive to form a group of industrial clusters with long product chains and strong industrial clustering.